89 results on '"Hourcade, D."'
Search Results
2. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement
- Author
-
White, D. J. G., Oglesby, T., Liszewski, M. K., Tedja, I., Hourcade, D., Wang, M. -W., Wright, L., Wallwork, J., Atkinson, J. P., Kootstra, Gauke, editor, Opelz, Gerhard, editor, Buurman, W. A., editor, van Hooff, J. P., editor, MacMaster, P., editor, and Wallwork, J., editor
- Published
- 1992
- Full Text
- View/download PDF
3. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation
- Author
-
Kavanagh, D., Burgess, R., Spitzer, D., Richards, A., Diaz-Torres, M. L., Goodship, J. A., Hourcade, D. E., Atkinson, J. P., and Goodship, T. H.J.
- Published
- 2007
- Full Text
- View/download PDF
4. Expansion of the Knops blood group system and subdivision of Sla
- Author
-
Moulds, J. M., Zimmerman, P. A., Doumbo, O. K., Diallo, D. A., Atkinson, J. P., Krych-Goldberg, M., Hourcade, D. E., and Moulds, J. J.
- Published
- 2002
5. Genome-wide association analysis of resistance to wheat spindle streak mosaic virus in bread wheat
- Author
-
Hourcade, D., primary, Bogard, M., additional, Bonnefoy, M., additional, Savignard, F., additional, Mohamadi, F., additional, Lafarge, S., additional, Du Cheyron, P., additional, Mangel, N., additional, and Cohan, J. P., additional
- Published
- 2018
- Full Text
- View/download PDF
6. The Regulators of Complement Activation (RCA) Gene Cluster
- Author
-
Hourcade, D., Atkinson, J. P., Melchers, Fritz, editor, Albert, E. D., editor, von Boehmer, H., editor, Dierich, M. P., editor, Du Pasquier, L., editor, Eichmann, K., editor, Gemsa, D., editor, Götze, O., editor, Kalden, J. R., editor, Kaufmann, S. H. E., editor, Kirchner, H., editor, Resch, K., editor, Riethmüller, G., editor, Schimpl, A., editor, Sorg, C., editor, Steinmetz, M., editor, Wagner, H., editor, and Zachau, H. G., editor
- Published
- 1989
- Full Text
- View/download PDF
7. Genome‐wide association analysis of resistance to wheat spindle streak mosaic virus in bread wheat.
- Author
-
Hourcade, D., Bogard, M., Bonnefoy, M., Savignard, F., Mohamadi, F., Mangel, N., Lafarge, S., Du Cheyron, P., and Cohan, J. P.
- Subjects
- *
WHEAT diseases & pests , *WHEAT streak mosaic virus , *GENOMES , *POLYMERASE chain reaction , *SELECTION (Plant breeding) - Abstract
Wheat spindle streak mosaic virus (WSSMV) is a major concern for cereal crops in Europe and North America. A strong increase in the occurrence of WSSMV has been observed in each French region where susceptible cultivars are cultivated. Most European bread wheat cultivars are resistant, but assessing the status of newly registered cultivars or breeding lines regarding WSSMV resistance is of importance. This paper describes a genome‐wide association study carried out on a panel of 163 cultivars and tested for their resistance to WSSMV. Two regions on chromosomes 5B and 7D showed minor effects on WSSMV resistance. More importantly, a large genomic region on chromosome 2D explained most of the resistance to WSSMV. More than 99% of the cultivars carrying the AA genotype at the most associated marker (Excalibur_c15426_661) were resistant to WSSMV, while 100% of the cultivars showing the GG genotype were susceptible. This large genomic region of 45.8 Mb was found distal to the centromere and showed very high linkage disequilibrium. It is hypothesized that this region may be an alien introgression originating from a wild related species. This region contains a total of 2605 predicted genes based on the Chinese Spring IWGSC RefSeq v. 1.0 including genes potentially involved in plant disease resistance. A kompetitive allele‐specific PCR (KASP) single‐nucleotide polymorphism (SNP) marker was designed in order to identify breeding lines or registered cultivars resistant to WSSMV. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. Mise au point d’outils améliorés pour l’évaluation des résistances variétales du blé tendre à Septoria tritici
- Author
-
Gouache, D., Hourcade, D., Lebrun, Marc-Henri, Marcel, Thierry, Ducasse, Aurélie, Audeon, Colette, Goyeau, Henriette, Suffert, Frederic, Michelet, C., Robert, O., Cadot, Valerie, Ghaffary, SMT, Khema, G.HJ, ARVALIS - Institut du végétal [Paris], BIOlogie et GEstion des Risques en agriculture (BIOGER), Institut National de la Recherche Agronomique (INRA)-AgroParisTech, Société Ragt 2N, Bioplante, 1314 Gip Geves Direction - Siège, Institut National de la Recherche Agronomique (INRA)-Gip Geves Direction - Siège (Gip Geves Direction - Siège)-Accueil GEVES (Accueil GEVES)-Groupe d'étude et de controle des variétés et des semences (GEVES), Plant Research International, and Wageningen University and Research [Wageningen] (WUR)
- Subjects
blé ,Septoria tritici ,[SDV]Life Sciences [q-bio] ,résistance - Abstract
absent
- Published
- 2012
9. Primary sequence of an alternatively spliced form of CR1. Candidate for the 75,000 M(r) complement receptor expressed on chimpanzee erythrocytes
- Author
-
Birmingham, D. J., Shen, X. -P, Hourcade, D., Nickells, M. W., and John Atkinson
- Subjects
Immunology ,Immunology and Allergy - Abstract
Chimpanzee erythrocytes express a 75,000 M(r) complement receptor (E-CR) that binds C3b bearing immune complexes and is recognized by an anti-CR1 mAb (E11). Human erythrocytes express the type 1 CR (CR1), the most common form being 220,000 M(r) and consisting of 30 short consensus repeats (SCRs) for its entire extracellular region. The purpose of this investigation was to determine the structure of the 75,000 M(r) chimpanzee E-CR. A chimpanzee cell line was identified that expressed a 220,000 M(r) CR1, and a 75,000 M(r) molecule that was recognized by E11 and could bind human C3i. Utilizing this cell line, chimpanzee CR1 cDNA was amplified in overlapping segments by the PCR, using primer pairs specific for various regions of human CR1 cDNA. Direct sequencing of the PCR-amplified products revealed 6044 nucleotides encoding the entire 220,000 M(r) chimpanzee CR1. This nucleotide sequence was 98.8% homologous to that of the human 220,000 M(r) CR1. Amplification using a CR1 primer from the signal peptide and from the cytoplasmic region yielded a 1985-bp PCR product, termed CR1a. The CR1a sequence was identical with the sequence encoding SCRs 1 to 6, SCRs 28 to 30, and the transmembrane and cytoplasmic regions of chimpanzee CR1. This alternatively spliced product of chimpanzee CR1 would encode a protein of 71,000 peptide m.w. with six potential N-glycosylation sites. Amplification employing a CR1 primer from SCR 1 and from the 3' untranslated region yielded a second PCR product of 1731 bp. This sequence, termed CR1b, encoded eight SCRs, followed by a hydrophobic region that ended in a stop codon. The first six SCRs of CR1b were closer in homology to the first six SCRs of a human CR1-like genomic sequence (97.4%) than to those of the chimpanzee CR1 (94.8%). Taken together, these sequence data suggest that the 75,000 M(r) chimpanzee E-CR is encoded by CR1a, an alternative splice variant of chimpanzee CR1. The CR1b is presumably derived from an RNA species related to the CR1-like genomic sequence previously described only in humans.
- Published
- 1994
- Full Text
- View/download PDF
10. Developing and sharing tools to bring benefits of resistance to Mycosphaerella graminicola to wheat growers in France: from breeding to cultivar registration and extension
- Author
-
Gouache, D., Hourcade, D., Lebrun, Marc-Henri, Marcel, Thierry, Audeon, Colette, Goyeau, Henriette, Suffert, Frederic, Michelet, C., Robert, O., Cadot, V., Kema, G.H.J., BIOlogie et GEstion des Risques en agriculture (BIOGER), and Institut National de la Recherche Agronomique (INRA)-AgroParisTech
- Subjects
[SDV.SA]Life Sciences [q-bio]/Agricultural sciences ,population ,virulence spectrum ,blé pathogène des plantes ,septoria leaf blotch ,host resistance ,epidemic - Abstract
absent
- Published
- 2011
11. Characterization of the promoter region of the membrane cofactor protein (CD46) gene of the human complement system and comparison to a membrane cofactor protein-like genetic element
- Author
-
Cui, W., Hourcade, D., Post, T., Greenlund, A. C., John Atkinson, and Kumar, V.
- Subjects
Immunology ,Immunology and Allergy - Abstract
Membrane cofactor protein (MCP; CD46) is a widely expressed C regulatory protein that inhibits C activation on self-tissue. MCP binds C3b and C4b deposited on autologous cells and then serves as a cofactor for their inactivation by limited proteolytic cleavage. To characterize the DNA sequence elements responsible for controlling MCP expression, the 5' flanking region of the human MCP gene was cloned. Sequencing of 1350 nucleotides upstream from the ATG codon revealed a GC-rich region in the initial 500 nucleotides that is especially rich in the CpG dinucleotide. A CAAT box in reverse orientation, surrounded by four putative SP1 binding sites but lacking a typical TATA element, was within the first 200 nucleotides of this GC-rich region. The major transcriptional initiation site for HeLa cells, determined by primer extension and S1 nuclease protection analyses, was located 105 nucleotides from the translational start site. This overall orientation of the promoter region is characteristic of "housekeeping" genes. The MCP promoter region was further examined in HEp-2 cells by the chloramphenicol acetyltransferase (CAT) reporter gene assay, using various constructs derived from the 5' region of the MCP gene. The MCP promoter activity was confined to the GC-rich region from -624 to +96 (start site of transcription being +1). Inclusion of an AT-rich sequence from -624 to -1204 resulted in a 42% reduction in CAT activity suggesting that an inhibitor is present among the AT-rich sequences. The 5' flanking region of a highly homologous partial duplication of the MCP gene was also cloned and sequenced, and various constructs were assessed in the CAT reporter system. Many of the functionally relevant sequences seen in MCP are also found in the MCP-like 5' UT region, which is 85% homologous to MCP. The most striking difference was a 224 nucleotide deletion that was upstream from the corresponding MCP region harboring most of the promoter activity. Although expression of an MCP-like protein has not been reported, the MCP-like promoter region produced promoter activity comparable with that of MCP. These results serve as a basis for subsequent analyses of the expression of MCP in various cells and tissues and for understanding the mechanism of its modulation in inflammatory conditions. Also, through a comparison of the 5' region of MCP with other genes in the regulators of C activation gene cluster (at 1 q32), we propose a model for the evolution of the promoters in this tight linkage group.(ABSTRACT TRUNCATED AT 400 WORDS)
- Published
- 1993
- Full Text
- View/download PDF
12. CR1 Sushi domains 2 and 3
- Author
-
Park, H.J., primary, Guariento, M.J., additional, Maciejewski, M., additional, Hauart, R., additional, Tham, W., additional, Cowman, A.F., additional, Schmidt, C.Q., additional, Martens, H., additional, Liszewski, K.M., additional, Hourcade, D., additional, Barlow, P.N., additional, and Atkinson, J.P., additional
- Published
- 2013
- Full Text
- View/download PDF
13. CR1 Sushi domains 1 and 2
- Author
-
Park, H.J., primary, Guariento, M.J., additional, Maciejewski, M., additional, Hauart, R., additional, Tham, W., additional, Cowman, A.F., additional, Schmidt, C.Q., additional, Martens, H., additional, Liszewski, K.M., additional, Hourcade, D., additional, Barlow, P.N., additional, and Atkinson, J.P., additional
- Published
- 2013
- Full Text
- View/download PDF
14. Measles virus spread and pathogenesis in genetically modified mice.
- Author
-
Mrkic, B, Pavlovic, J, Rülicke, T, Volpe, P, Buchholz, C J, Hourcade, D, Atkinson, J P, Aguzzi, A; https://orcid.org/0000-0002-0344-6708, Cattaneo, R, Mrkic, B, Pavlovic, J, Rülicke, T, Volpe, P, Buchholz, C J, Hourcade, D, Atkinson, J P, Aguzzi, A; https://orcid.org/0000-0002-0344-6708, and Cattaneo, R
- Abstract
Attenuated Edmonston measles virus (MV-Edm) is not pathogenic in standard mice. We show here that MV-Edm inoculated via the natural respiratory route has a limited propagation in the lungs of mice with a targeted mutation inactivating the alpha/beta interferon receptor. A high dose of MV-Edm administered intracerebrally is lethal for about half of these mice. To study the consequences of the availability of a high-affinity receptor for MV propagation, we generated alpha/beta interferon-defective mice expressing human CD46 with human-like tissue specificity. Intranasal infection of these mice with MV-Edm resulted in enhanced spread to the lungs and more prominent inflammatory response. Virus replication was also detected in peripheral blood mononuclear cells, the spleen, and the liver. Moreover, intracerebral inoculation of adult animals with low MV-Edm doses caused encephalitis with almost inevitably lethal outcome. We conclude that in mice alpha/beta interferon controls MV infection and that a high-affinity receptor facilitates, but is not strictly required for, MV spread and pathogenesis.
- Published
- 1998
15. CR1: evolving to the tune of a powerful pathogen
- Author
-
Krych-Goldberg, M., primary, Hauhart, R., additional, Hourcade, D., additional, and Atkinson, J.P., additional
- Published
- 2002
- Full Text
- View/download PDF
16. Molecular identification of the CR1-related blood group antigens implicated in malarial infection
- Author
-
Moulds, JM, primary, Zimmerman, P, additional, Birmingham, D, additional, Doumbo, O, additional, Kassambara, L, additional, Sagara, I, additional, Atkinson, JP, additional, Krych, M, additional, Hourcade, D, additional, and Miller, L, additional
- Published
- 2000
- Full Text
- View/download PDF
17. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
- Author
-
Kim, Y U, primary, Kinoshita, T, additional, Molina, H, additional, Hourcade, D, additional, Seya, T, additional, Wagner, L M, additional, and Holers, V M, additional
- Published
- 1995
- Full Text
- View/download PDF
18. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis.
- Author
-
Krych, M., primary, Clemenza, L., additional, Howdeshell, D., additional, Hauhart, R., additional, Hourcade, D., additional, and Atkinson, J.P., additional
- Published
- 1994
- Full Text
- View/download PDF
19. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.
- Author
-
Krych, M, primary, Hourcade, D, additional, and Atkinson, J P, additional
- Published
- 1991
- Full Text
- View/download PDF
20. Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene. An example of concerted (horizontal) evolution within a gene.
- Author
-
Hourcade, D, primary, Miesner, D R, additional, Bee, C, additional, Zeldes, W, additional, and Atkinson, J P, additional
- Published
- 1990
- Full Text
- View/download PDF
21. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.
- Author
-
Krych-Goldberg, M, Hauhart, R E, Subramanian, V B, Yurcisin, B M, Crimmins, D L, Hourcade, D E, and Atkinson, J P
- Abstract
The goal of this study was to identify the site(s) in CR1 that mediate the dissociation of the C3 and C5 convertases. To that end, truncated derivatives of CR1 whose extracellular part is composed of 30 tandem repeating modules, termed complement control protein repeats (CCPs), were generated. Site 1 (CCPs 1-3) alone mediated the decay acceleration of the classical and alternative pathway C3 convertases. Site 2 (CCPs 8-10 or the nearly identical CCPs 15-17) had one-fifth the activity of site 1. In contrast, for the C5 convertase, site 1 had only 0.5% of the decay accelerating activity, while site 2 had no detectable activity. Efficient C5 decay accelerating activity was detected in recombinants that carried both site 1 and site 2. The activity was reduced if the intervening repeats between site 1 and site 2 were deleted. The results indicate that, for the C5 convertases, decay accelerating activity is mediated primarily by site 1. A properly spaced site 2 has an important auxiliary role, which may involve its C3b binding capacity. Moreover, using homologous substitution mutagenesis, residues important in site 1 for dissociating activity were identified. Based on these results, we generated proteins one-fourth the size of CR1 but with enhanced decay accelerating activity for the C3 convertases.
- Published
- 1999
22. Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis.
- Author
-
Hourcade, D E, Wagner, L M, and Oglesby, T J
- Abstract
Human factor B is required for the initiation and propagation of the complement alternative pathway. It also participates in the amplification of the complement classical pathway. Alone, factor B is a zymogen with little known biochemical activity, but in the context of the alternative pathway convertases, the factor B serine protease is activated in a process that first involves the association with C3b and subsequently the cleavage of factor B into two fragments, Ba and Bb. Ba, the NH2-terminal fragment, is composed mainly of three tandem short consensus repeats, globular domains found in other complement proteins. It dissociates from the convertase during assembly, leaving the active C3 convertase, C3bBb. Previous reports suggest that the Ba region may be instrumental in convertase assembly. This hypothesis was tested using site-directed mutagenesis of recombinant factor B and monoclonal antibody epitope mapping to evaluate the relative importance of specific short consensus repeat amino acid residues. Three sites of interest were identified. Site 1 is a stretch of 19 contiguous amino acids in short consensus repeat 1 that form the epitope of a monoclonal antibody that effectively blocks factor B function. Site 2, composed of 6 contiguous amino acids in short consensus repeat 2, and site 3, consisting of 7 contiguous amino acids in short consensus repeat 3, were defined by mutations that reduce factor B hemolytic activity to 3% or less. Further analyses indicated that sites 2 and 3 contribute to factor B-C3b interactions.
- Published
- 1995
23. A conserved element in the serine protease domain of complement factor B.
- Author
-
Hourcade, D E, Mitchell, L M, and Oglesby, T J
- Abstract
Factor B and C2 are serine proteases that carry the catalytic sites of the complement C3 and C5 convertases. Their protease domains are activated by conformational changes that occur during convertase assembly and are deactivated upon convertase dissociation. Factor B and C2 share an 8-amino acid conserved sequence near their serine protease termini that is not seen in other serine proteases. To determine its importance, 24 factor B mutants were generated, each with a single amino acid substitution in this region. Whereas most mutants were functionally neutral, all five different substitutions of aspartic acid 715 and one phenylalanine 716 substitution severely reduced hemolytic activity. Several aspartic acid 715 mutants permitted the steps of convertase assembly including C3b-dependent factor D-mediated cleavage and activation of the high affinity C3b-binding site, but the resulting complexes did not cleave C3. Given that factor B and C2 share the same biological substrates and that part of the trypsin-like substrate specificity region is not apparent in either protein, we propose that the conserved region plays a critical role in the conformational regulation of the catalytic site and could offer a highly specific target for the therapeutic inhibition of complement.
- Published
- 1998
24. Site-specific initiation of a DNA fragment.
- Author
-
Hourcade, D and Dressler, D
- Abstract
The first step in the replication cycle of the single-stranded DNA phages is the conversion of the infecting positive strand circle to a duplex ring. This event involves the de novo initiation of a negative strand, using the infecting positive strand cycle as a template. The synthesis of the negative strand is in many respects analogous to the formation of a fragment during cellular DNA replication. In this paper we describe the initiation of the negative strand of bacteriophage G4. The data establish that, in vivo, the synthesis of the G4 negative strand is initiated at a specific site, which we have mapped on the 5400-base viral chromosome.
- Published
- 1978
- Full Text
- View/download PDF
25. Primary sequence of baboon CR1 demonstrates concerted evolution within the CR1 gene
- Author
-
Clemenza, L., Subramanian, B., Hourcade, D., Nickells, M., and Atkinson, J.
- Published
- 1997
- Full Text
- View/download PDF
26. Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1.
- Author
-
Hourcade, D, Miesner, D R, Atkinson, J P, and Holers, V M
- Abstract
The human C3b/C4b receptor or complement receptor type one (CR1) is an approximately 200-kD single chain membrane glycoprotein of human peripheral blood cells that mediates the binding, processing, and transport of C3b-bearing immune complexes and regulates the activity of the complement cascade. Analysis of partial cDNA clones has shown that the COOH terminus is composed predominantly of three tandemly repeated regions of 450 amino acids each (15). In this report, we present a cDNA sequence that encodes the NH2 terminus of CR1. It appears to have been derived from an alternatively processed transcript, caused by polyadenylation occurring at a site within an intron in the CR1 transcriptional unit. The resulting truncated messenger carries an open reading frame that would produce a short, secreted CR1 form. We present genomic sequences and Northern blots which support this hypothesis and we propose that the NH2-terminal end of CR1 is a likely location for active sites. In addition, we report evidence for a CR1-like sequence in the human genome and we present a model for the organization of CR1.
- Published
- 1988
- Full Text
- View/download PDF
27. The Nucleolus and the Rolling Circle
- Author
-
Hourcade, D., primary, Dressler, D., additional, and Wolfson, J., additional
- Published
- 1974
- Full Text
- View/download PDF
28. Identification and interest of molecular markers to monitor plant Pi status.
- Author
-
Cuyas L, David P, de Craieye D, Ng S, Arkoun M, Plassard C, Faharidine M, Hourcade D, Degan F, Pluchon S, and Nussaume L
- Subjects
- Biomarkers, Phenotype, Phosphates, Crops, Agricultural genetics, Arabidopsis genetics
- Abstract
Background: Inorganic phosphate (Pi) is the sole source of phosphorus for plants. It is a limiting factor for plant yield in most soils worldwide. Due to economic and environmental constraints, the use of Pi fertilizer is and will be more and more limited. Unfortunately, evaluation of Pi bioavailability or Pi starvation traits remains a tedious task, which often does not inform us about the real Pi plant status., Results: Here, we identified by transcriptomic studies carried out in the plant model Arabidopsis thaliana, early roots- or leaves-conserved molecular markers for Pi starvation, exhibiting fast response to modifications of phosphate nutritional status. We identified their homologues in three crops (wheat, rapeseed, and maize) and demonstrated that they offer a reliable opportunity to monitor the actual plant internal Pi status. They turn out to be very sensitive in the concentration range of 0-50 µM which is the most common case in the vast majority of soils and situations where Pi hardly accumulates in plants. Besides in vitro conditions, they could also be validated for plants growing in the greenhouse or in open field conditions., Conclusion: These markers provide valuable physiological tools for plant physiologists and breeders to assess phosphate bio-availability impact on plant growth in their studies. This also offers the opportunity to cope with the rising economical (shortage) and societal problems (pollution) resulting from the management of this critical natural resource., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
29. Corrigendum to: Marker-based crop model assisted ideotype design to improve avoidance of abiotic stress in bread wheat.
- Author
-
Bogard M, Hourcade D, Piquemal B, Gouache D, Deswartes JC, Throude M, and Cohan JP
- Published
- 2021
- Full Text
- View/download PDF
30. Marker-based crop model-assisted ideotype design to improve avoidance of abiotic stress in bread wheat.
- Author
-
Bogard M, Hourcade D, Piquemal B, Gouache D, Deswartes JC, Throude M, and Cohan JP
- Subjects
- Crops, Agricultural genetics, France, Stress, Physiological, Triticum genetics
- Abstract
Wheat phenology allows escape from seasonal abiotic stresses including frosts and high temperatures, the latter being forecast to increase with climate change. The use of marker-based crop models to identify ideotypes has been proposed to select genotypes adapted to specific weather and management conditions and anticipate climate change. In this study, a marker-based crop model for wheat phenology was calibrated and tested. Climate analysis of 30 years of historical weather data in 72 locations representing the main wheat production areas in France was performed. We carried out marker-based crop model simulations for 1019 wheat cultivars and three sowing dates, which allowed calculation of genotypic stress avoidance frequencies of frost and heat stress and identification of ideotypes. The phenology marker-based crop model allowed prediction of large genotypic variations for the beginning of stem elongation (GS30) and heading date (GS55). Prediction accuracy was assessed using untested genotypes and environments, and showed median genotype prediction errors of 8.5 and 4.2 days for GS30 and GS55, respectively. Climate analysis allowed the definition of a low risk period for each location based on the distribution of the last frost and first heat days. Clustering of locations showed three groups with contrasting levels of frost and heat risks. Marker-based crop model simulations showed the need to optimize the genotype depending on sowing date, particularly in high risk environments. An empirical validation of the approach showed that it holds good promises to improve frost and heat stress avoidance., (© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Experimental Biology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
31. Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy.
- Author
-
Ford AL, Chin VW, Fellah S, Binkley MM, Bodin AM, Balasetti V, Taiwo Y, Kang P, Lin D, Jen JC, Grand MG, Bogacki M, Liszewski MK, Hourcade D, Chen Y, Hassenstab J, Lee JM, An H, Miner JJ, and Atkinson JP
- Subjects
- Adult, Cognitive Dysfunction diagnostic imaging, Female, Hereditary Central Nervous System Demyelinating Diseases diagnostic imaging, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Nerve Degeneration diagnostic imaging, Neuroimaging methods, Retinal Diseases diagnostic imaging, Vascular Diseases diagnostic imaging, White Matter diagnostic imaging, Cognitive Dysfunction pathology, Hereditary Central Nervous System Demyelinating Diseases pathology, Nerve Degeneration pathology, Retinal Diseases pathology, Vascular Diseases pathology, White Matter pathology
- Abstract
Objective: To characterize lesion evolution and neurodegeneration in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) using multimodal MRI., Methods: We prospectively performed MRI and cognitive testing in RVCL-S and healthy control cohorts. Gray and white matter volume and disruption of white matter microstructure were quantified. Asymmetric spin echo acquisition permitted voxel-wise oxygen extraction fraction (OEF) calculation as an in vivo marker of microvascular ischemia. The RVCL-S cohort was included in a longitudinal analysis of lesion subtypes in which hyperintense lesions on fluid-attenuated inversion recovery (FLAIR), T1-postgadolinium, and diffusion-weighted imaging were delineated and quantified volumetrically., Results: Twenty individuals with RVCL-S and 26 controls were enrolled. White matter volume and microstructure declined faster in those with RVCL-S compared to controls. White matter atrophy in RVCL-S was highly linear (ρ = -0.908, p < 0.0001). Normalized OEF was elevated in RVCL-S and increased with disease duration. Multiple cognitive domains, specifically those measuring working memory and processing speed, were impaired in RVCL-S. Lesion volumes, regardless of subtype, progressed/regressed with high variability as a function of age, while FLAIR lesion burden increased near time to death ( p < 0.001)., Conclusion: RVCL-S is a monogenic microvasculopathy affecting predominantly the white matter with regard to atrophy and cognitive impairment. White matter volumes in RVCL-S declined linearly, providing a potential metric against which to test the efficacy of future therapies. Progressive elevation of white matter OEF suggests that microvascular ischemia may underlie neurodegeneration in RVCL-S., (Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.)
- Published
- 2020
- Full Text
- View/download PDF
32. A saturated SNP linkage map for the orange wheat blossom midge resistance gene Sm1.
- Author
-
Kassa MT, Haas S, Schliephake E, Lewis C, You FM, Pozniak CJ, Krämer I, Perovic D, Sharpe AG, Fobert PR, Koch M, Wise IL, Fenwick P, Berry S, Simmonds J, Hourcade D, Senellart P, Duchalais L, Robert O, Förster J, Thomas JB, Friedt W, Ordon F, Uauy C, and McCartney CA
- Subjects
- Animals, Brachypodium genetics, Chironomidae, DNA, Plant genetics, Genes, Plant, Genetic Markers, Haplotypes, Oryza genetics, Phenotype, Chromosome Mapping, Genetic Linkage, Polymorphism, Single Nucleotide, Synteny, Triticum genetics
- Abstract
Key Message: SNP markers were developed for the OWBM resistance gene Sm1 that will be useful for MAS. The wheat Sm1 region is collinear with an inverted syntenic interval in B. distachyon. Orange wheat blossom midge (OWBM, Sitodiplosis mosellana Géhin) is an important insect pest of wheat (Triticum aestivum) in many growing regions. Sm1 is the only described OWBM resistance gene and is the foundation of managing OWBM through host genetics. Sm1 was previously mapped to wheat chromosome arm 2BS relative to simple sequence repeat (SSR) markers and the dominant, sequence characterized amplified region (SCAR) marker WM1. The objectives of this research were to saturate the Sm1 region with markers, develop improved markers for marker-assisted selection (MAS), and examine the synteny between wheat, Brachypodium distachyon, and rice (Oryza sativa) in the Sm1 region. The present study mapped Sm1 in four populations relative to single nucleotide polymorphisms (SNPs), SSRs, Diversity Array Technology (DArT) markers, single strand conformation polymorphisms (SSCPs), and the SCAR WM1. Numerous high quality SNP assays were designed that mapped near Sm1. BLAST delineated the syntenic intervals in B. distachyon and rice using gene-based SNPs as query sequences. The Sm1 region in wheat was inverted relative to B. distachyon and rice, which suggests a chromosomal rearrangement within the Triticeae lineage. Seven SNPs were tested on a collection of wheat lines known to carry Sm1 and not to carry Sm1. Sm1-flanking SNPs were identified that were useful for predicting the presence or absence of Sm1 based upon haplotype. These SNPs will be a major improvement for MAS of Sm1 in wheat breeding programs.
- Published
- 2016
- Full Text
- View/download PDF
33. Exploiting the Repetitive Fraction of the Wheat Genome for High-Throughput Single-Nucleotide Polymorphism Discovery and Genotyping.
- Author
-
Cubizolles N, Rey E, Choulet F, Rimbert H, Laugier C, Balfourier F, Bordes J, Poncet C, Jack P, James C, Gielen J, Argillier O, Jaubertie JP, Auzanneau J, Rohde A, Ouwerkerk PB, Korzun V, Kollers S, Guerreiro L, Hourcade D, Robert O, Devaux P, Mastrangelo AM, Feuillet C, Sourdille P, and Paux E
- Subjects
- Genome-Wide Association Study, Genotype, Triticum classification, Genome, Plant, Genotyping Techniques methods, Polymorphism, Single Nucleotide genetics, Repetitive Sequences, Nucleic Acid genetics, Triticum genetics
- Abstract
Transposable elements (TEs) account for more than 80% of the wheat genome. Although they represent a major obstacle for genomic studies, TEs are also a source of polymorphism and consequently of molecular markers such as insertion site-based polymorphism (ISBP) markers. Insertion site-based polymorphisms have been found to be a great source of genome-specific single-nucleotide polymorphism (SNPs) in the hexaploid wheat ( L.) genome. Here, we report on the development of a high-throughput SNP discovery approach based on sequence capture of ISBP markers. By applying this approach to the reference sequence of chromosome 3B from hexaploid wheat, we designed 39,077 SNPs that are evenly distributed along the chromosome. We demonstrate that these SNPs can be efficiently scored with the KASPar (Kompetitive allele-specific polymerase chain reaction) genotyping technology. Finally, through genetic diversity and genome-wide association studies, we also demonstrate that ISBP-derived SNPs can be used in marker-assisted breeding programs., (Copyright © 2016 Crop Science Society of America.)
- Published
- 2016
- Full Text
- View/download PDF
34. Annexin A2 Enhances Complement Activation by Inhibiting Factor H.
- Author
-
Renner B, Tong HH, Laskowski J, Jonscher K, Goetz L, Woolaver R, Hannan J, Li YX, Hourcade D, Pickering MC, Holers VM, and Thurman JM
- Subjects
- Acute Kidney Injury immunology, Animals, Blotting, Western, Chromatography, Liquid, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Fluorescent Antibody Technique, Immunohistochemistry, Immunoprecipitation, Mass Spectrometry, Mice, Mice, Inbred C57BL, Otitis Media immunology, Reperfusion Injury immunology, Reverse Transcriptase Polymerase Chain Reaction, Annexin A2 immunology, Complement Activation immunology, Complement Factor H immunology
- Abstract
Factor H is a circulating protein that regulates activation of the alternative pathway (AP) of complement. Mutations and genetic variations of factor H are associated with several AP-mediated diseases, highlighting the critical role of factor H in AP regulation. AP-mediated inflammation is typically triggered by illness or tissue injury, however, and tissue injury can trigger AP activation in individuals with fully functional factor H. This suggests that factor H function is affected by local conditions within tissues. We hypothesized that inducible proteins impair the ability of factor H to locally control the AP, thereby increasing AP activation. We used purified murine factor H to immunoprecipitate binding partners from mouse kidneys. Using immunoaffinity liquid chromatography-mass spectrometry, we identified annexin A2 as a factor H binding partner. Further experiments showed that annexin A2 reduces the binding of factor H to cell surfaces. Recombinant annexin A2 impaired complement regulation by factor H and increased complement activation on renal cell surfaces in vitro and in vivo. In a murine model of acute pneumococcal otitis media, the administration of annexin A2 increased AP-mediated bacterial opsonization and clearance. In conclusion, the local production of annexin A2 within tissues suppresses regulation of the AP by factor H. Annexin A2 can contribute to AP-mediated tissue inflammation by locally impairing factor H function, but it can also improve complement-mediated bacterial clearance., (Copyright © 2016 by The American Association of Immunologists, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
35. Control of flowering and cell fate by LIF2, an RNA binding partner of the polycomb complex component LHP1.
- Author
-
Latrasse D, Germann S, Houba-Hérin N, Dubois E, Bui-Prodhomme D, Hourcade D, Juul-Jensen T, Le Roux C, Majira A, Simoncello N, Granier F, Taconnat L, Renou JP, and Gaudin V
- Subjects
- Arabidopsis genetics, Arabidopsis Proteins genetics, Arabidopsis Proteins physiology, Cell Lineage, Chromosomal Proteins, Non-Histone genetics, Chromosomal Proteins, Non-Histone physiology, Epigenesis, Genetic, Gene Expression Profiling, Gene Expression Regulation, Plant, Multiprotein Complexes, Mutation, Protein Binding, RNA-Binding Proteins genetics, RNA-Binding Proteins physiology, Arabidopsis physiology, Arabidopsis Proteins metabolism, Chromosomal Proteins, Non-Histone metabolism, Flowers, RNA-Binding Proteins metabolism
- Abstract
Polycomb Repressive Complexes (PRC) modulate the epigenetic status of key cell fate and developmental regulators in eukaryotes. The chromo domain protein like heterochromatin protein1 (LHP1) is a subunit of a plant PRC1-like complex in Arabidopsis thaliana and recognizes histone H3 lysine 27 trimethylation, a silencing epigenetic mark deposited by the PRC2 complex. We have identified and studied an LHP1-Interacting Factor2 (LIF2). LIF2 protein has RNA recognition motifs and belongs to the large hnRNP protein family, which is involved in RNA processing. LIF2 interacts in vivo, in the cell nucleus, with the LHP1 chromo shadow domain. Expression of LIF2 was detected predominantly in vascular and meristematic tissues. Loss-of-function of LIF2 modifies flowering time, floral developmental homeostasis and gynoecium growth determination. lif2 ovaries have indeterminate growth and produce ectopic inflorescences with severely affected flowers showing proliferation of ectopic stigmatic papillae and ovules in short-day conditions. To look at how LIF2 acts relative to LHP1, we conducted transcriptome analyses in lif2 and lhp1 and identified a common set of deregulated genes, which showed significant enrichment in stress-response genes. By comparing expression of LHP1 targets in lif2, lhp1 and lif2 lhp1 mutants we showed that LIF2 can either antagonize or act with LHP1. Interestingly, repression of the FLC floral transcriptional regulator in lif2 mutant is accompanied by an increase in H3K27 trimethylation at the locus, without any change in LHP1 binding, suggesting that LHP1 is targeted independently from LIF2 and that LHP1 binding does not strictly correlate with gene expression. LIF2, involved in cell identity and cell fate decision, may modulate the activity of LHP1 at specific loci, during specific developmental windows or in response to environmental cues that control cell fate determination. These results highlight a novel link between plant RNA processing and Polycomb regulation.
- Published
- 2011
- Full Text
- View/download PDF
36. Mapping of a spontaneous mutation for early flowering time in maize highlights contrasting allelic series at two-linked QTL on chromosome 8.
- Author
-
Chardon F, Hourcade D, Combes V, and Charcosset A
- Subjects
- Alleles, Genes, Plant, Genetic Markers, Genome, Plant, Oryza genetics, Phenotype, Zea mays anatomy & histology, Zea mays physiology, Chromosome Mapping, Chromosomes, Plant, Flowers, Mutation, Quantitative Trait Loci, Zea mays genetics
- Abstract
Only a few mutations affecting flowering time have been detected in maize. We analyzed a spontaneous early mutation, vgt-f7p, which appeared during production of the inbred line F7. This mutation shortens the time from planting to flowering by about 100 growing degree days (GDD), and reduces the number of nodes. It therefore seems to affect the timing of meristem differentiation from a vegetative to a reproductive state. It was mapped to a 6 cM confidence interval on chromosome 8, using a QTL mapping approach. QTL analysis of a mapping population generated by crossing the mutant F7 line (F7p) and the Gaspé flint population showed that vgt-f7p is probably allelic to vgt1, a QTL described in previous studies, and affects earliness more strongly than the Gaspé allele at vgt1. Global analysis of the QTL in the region suggested that there may be two consensus QTL, vgt1 and vgt2. These two QTL have contrasting allelic effects: rare alleles conferring extremely early flowering at vgt1 vs. greater diversity and milder effects at locus vgt2. Finally, detailed syntenic analysis showed that the vgt1 region displays a highly conserved duplicated region on chromosome 6, which also plays an important role in maize flowering time variation. The cloning of vgt1 should, therefore, also facilitate the analysis of the molecular basis of variation due to this second region.
- Published
- 2005
- Full Text
- View/download PDF
37. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.
- Author
-
Thurman JM, Kraus DM, Girardi G, Hourcade D, Kang HJ, Royer PA, Mitchell LM, Giclas PC, Salmon J, Gilkeson G, and Holers VM
- Subjects
- Animals, Antibodies, Monoclonal pharmacology, Antibodies, Monoclonal therapeutic use, Complement Factor B antagonists & inhibitors, Complement Factor B immunology, Disease Models, Animal, Epitope Mapping, Female, Fetal Death immunology, Humans, Mice, Mice, Knockout, Pregnancy, Pregnancy Complications, Hematologic drug therapy, Antibodies, Antiphospholipid adverse effects, Complement Activation drug effects, Fetal Death prevention & control
- Abstract
Studies in gene-targeted mice have demonstrated that factor B of the alternative complement pathway plays an important role in several disease models, but an exogenous inhibitor of factor B has not previously been available. We have developed an inhibitory monoclonal antibody directed against a critical epitope on mouse factor B and have tested it in a model of antiphospholipid (aPL) antibody (Ab)-induced fetal loss. Gene-targeted factor B-deficient mice (fB-/-) were injected with a fusion protein comprised of the second and third short consensus repeat (SCR) domains of mouse factor B linked to a mouse IgG1 Fc domain. Hybridomas were made from splenocytes of the immunized mouse. One mAb, designated 1379, produced an IgG1 antibody that inhibited alternative pathway activation in vitro and in vivo by preventing formation of the C3bBb complex. Strikingly, this mAb inhibited alternative pathway activation in serum from mice, rats, humans, monkeys, pigs and horses. Fab fragments made from this mAb also inhibited alternative pathway activation. Epitope mapping demonstrated that this antibody binds to factor B within the third SCR domain. When mAb 1379 was administered to mice that also received human IgG containing antiphospholipid antibodies, it provided significant protection from antiphospholipid antibody-induced complement activation and fetal loss. Thus, this mAb to factor B has broad species reactivity and effectively inhibits alternative pathway activation. The mAb protects mice in an in vivo model of antiphospholipid antibody syndrome, demonstrating the therapeutic potential for the inhibition of factor B in this disease.
- Published
- 2005
- Full Text
- View/download PDF
38. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
- Author
-
Barilla-LaBarca ML, Liszewski MK, Lambris JD, Hourcade D, and Atkinson JP
- Subjects
- Animals, Antigens, CD biosynthesis, Antigens, CD genetics, CHO Cells immunology, CHO Cells metabolism, Complement C5 metabolism, Complement C5b, Complement Factor H physiology, Complement Inactivator Proteins physiology, Complement Pathway, Alternative, Complement Pathway, Classical genetics, Cricetinae, Dose-Response Relationship, Immunologic, Humans, Hydrolysis, Membrane Cofactor Protein, Membrane Glycoproteins biosynthesis, Membrane Glycoproteins genetics, Membrane Proteins metabolism, Peptide Fragments metabolism, Protein Binding immunology, Transfection, Antigens, CD physiology, Complement C3b metabolism, Complement C4b metabolism, Membrane Glycoproteins physiology
- Abstract
C4b and C3b deposited on host cells undergo limited proteolytic cleavage by regulatory proteins. Membrane cofactor protein (MCP; CD46), factor H, and C4b binding protein mediate this reaction, known as cofactor activity, that also requires the plasma serine protease factor I. To explore the roles of the fluid phase regulators vs those expressed on host cells, a model system was used examining complement fragments deposited on cells transfected with human MCP as assessed by FACS and Western blotting. Following incubation with Ab and complement on MCP(+) cells, C4b was progressively cleaved over the first hour to C4d and C4c. There was no detectable cleavage of C4b on MCP(-) cells, indicating that MCP (and not C4BP in the serum) primarily mediates this cofactor activity. C3b deposition was not blocked on MCP(+) cells because classical pathway activation occurred before substantial C4b cleavage. Cleavage, though, of deposited C3b was rapid (<5 min) and iC3b was the dominant fragment on MCP(-) and MCP(+) cells. Studies using a function-blocking mAb further established factor H as the responsible cofactor. If the level of Ab sensitization was reduced 8-fold or if Mg(2+)-EGTA was used to block the classical pathway, MCP efficiently inhibited C3b deposition mediated by the alternative pathway. Thus, for the classical pathway, MCP is the cofactor for C4b cleavage and factor H for C3b cleavage. However, if the alternative pathway mediates C3b deposition, then MCP's cofactor activity is sufficient to restrict complement activation.
- Published
- 2002
- Full Text
- View/download PDF
39. Characterization of the active sites in decay-accelerating factor.
- Author
-
Kuttner-Kondo LA, Mitchell L, Hourcade DE, and Medof ME
- Subjects
- Amino Acid Sequence, Amino Acid Substitution genetics, Amino Acid Substitution immunology, Animals, Antigens, CD chemistry, Binding Sites immunology, CD55 Antigens genetics, Complement C3-C5 Convertases antagonists & inhibitors, Complement C3-C5 Convertases metabolism, Complement Inactivator Proteins chemistry, Complement Inactivator Proteins genetics, Complement Inactivator Proteins metabolism, Complement Pathway, Classical genetics, Genetic Variation immunology, Humans, Macaca mulatta, Membrane Cofactor Protein, Membrane Glycoproteins chemistry, Models, Molecular, Molecular Sequence Data, Mutagenesis, Site-Directed, Repetitive Sequences, Amino Acid, Sequence Homology, Amino Acid, Viral Proteins chemistry, CD55 Antigens chemistry, CD55 Antigens metabolism
- Abstract
Decay-accelerating factor (DAF) is a complement regulator that dissociates autologous C3 convertases, which assemble on self cell surfaces. Its activity resides in the last three of its four complement control protein repeats (CCP2-4). Previous modeling on the nuclear magnetic resonance structure of CCP15-16 in the serum C3 convertase regulator factor H proposed a positively charged surface area on CCP2 extending into CCP3, and hydrophobic moieties between CCPs 2 and 3 as being primary convertase-interactive sites. To map the residues providing for the activity of DAF, we analyzed the functions of 31 primarily alanine substitution mutants based in part on this model. Replacing R69, R96, R100, and K127 in the positively charged CCP2-3 groove or hydrophobic F148 and L171 in CCP3 markedly impaired the function of DAF in both activation pathways. Significantly, mutations of K126 and F169 and of R206 and R212 in downstream CCP4 selectively reduced alternative pathway activity without affecting classical pathway activity. Rhesus macaque DAF has all the above human critical residues except for F169, which is an L, and its CCPs exhibited full activity against the human classical pathway C3 convertase. The recombinants whose function was preferentially impaired against the alternative pathway C3bBb compared with the classical pathway C4b2a were tested in classical pathway C5 convertase (C4b2a3b) assays. The effects on C4b2a and C4b2a3b were comparable, indicating that DAF functions similarly on the two enzymes. When CCP2-3 of DAF were oriented according to the crystal structure of CCP1-2 of membrane cofactor protein, the essential residues formed a contiguous region, suggesting a similar spatial relationship.
- Published
- 2001
- Full Text
- View/download PDF
40. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1.
- Author
-
Moulds JM, Zimmerman PA, Doumbo OK, Kassambara L, Sagara I, Diallo DA, Atkinson JP, Krych-Goldberg M, Hauhart RE, Hourcade DE, McNamara DT, Birmingham DJ, Rowe JA, Moulds JJ, and Miller LH
- Subjects
- Animals, Blood Group Antigens immunology, Blood Grouping and Crossmatching, Erythrocytes immunology, Humans, Plasmodium falciparum, Polymorphism, Genetic, Receptors, Complement 3b immunology, Blood Group Antigens genetics, Receptors, Complement 3b genetics
- Abstract
Complement receptor 1 (CR1) has been implicated in rosetting of uninfected red blood cells to Plasmodium falciparum-infected cells, and rosette formation is associated with severe malaria. The Knops blood group (KN) is located on CR1 and some of these antigens, ie, McCoy (McC) and Swain-Langley (Sl(a)), show marked frequency differences between Caucasians and Africans. Thus, defining the molecular basis of these antigens may provide new insight into the mechanisms of P falciparum malaria. Monoclonal antibody epitope mapping and serologic inhibition studies using CR1 deletion constructs localized McC and Sl(a) to long homologous repeat D of CR1. Direct DNA sequencing of selected donors identified several single nucleotide polymorphisms in exon 29 coding for complement control protein modules 24 and 25. Two of these appeared to be blood group specific: McC associated with K1590E and Sl(a) with R1601G. These associations were confirmed by inhibition studies using allele-specific mutants. A sequence-specific oligonucleotide probe hybridization assay was developed to genotype several African populations and perform family inheritance studies. Concordance between the 1590 mutation and McC was 94%; that between Sl(a) and 1601 was 88%. All but 2 samples exhibiting discrepancies between the genotype and phenotype were found to be due to low red cell CR1 copy numbers, low or absent expression of some alleles, or heterozygosity combined with low normal levels of CR1. These data further explain the variability observed in previous serologic studies of CR1 and show that DNA and protein-based genetic studies will be needed to clarify the role of the KN antigens in malaria.
- Published
- 2001
- Full Text
- View/download PDF
41. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
- Author
-
Hourcade D, Liszewski MK, Krych-Goldberg M, and Atkinson JP
- Subjects
- Animals, Antigens, CD genetics, Antigens, CD physiology, Biological Evolution, CD55 Antigens genetics, CD55 Antigens physiology, Complement Activation, Genetic Variation, Humans, Infections immunology, Membrane Cofactor Protein, Membrane Glycoproteins genetics, Membrane Glycoproteins physiology, Protein Structure, Tertiary, Receptors, Complement 3b genetics, Receptors, Complement 3b physiology, Antigens, CD chemistry, CD55 Antigens chemistry, Membrane Glycoproteins chemistry, Receptors, Complement 3b chemistry
- Abstract
The Regulators of Complement Activation (RCA) are a fascinating group of proteins that play important roles in innate and acquired immunity. In this review, we examine structure-function aspects of three membrane-bound RCA proteins and discuss the unique impact of their genetic organization on their evolution.
- Published
- 2000
- Full Text
- View/download PDF
42. Decay acceleration of the complement alternative pathway C3 convertase.
- Author
-
Hourcade DE, Mitchell LM, and Medof ME
- Subjects
- CD55 Antigens immunology, Complement C3-C5 Convertases immunology, Complement Factor H genetics, Complement Factor H immunology, Complement Factor H metabolism, Complement Pathway, Alternative immunology, Enzyme-Linked Immunosorbent Assay, Humans, Immune Adherence Reaction, Kinetics, Mutagenesis, Site-Directed, CD55 Antigens metabolism, Complement C3-C5 Convertases metabolism, Complement Pathway, Alternative physiology
- Abstract
An ELISA-based method is described for analyzing the mechanism by which the decay of the alternative pathway C3 convertase is accelerated by C3 regulatory proteins. Using this assay, we show that human decay-accelerating factor (DAF) and factor H are active on mature convertase complexes (C3bBb) but not on their nascent precursor (C3bB). This finding has implications on the mechanisms of action of these two regulators. The complement convertases cleave the serum protein C3, and the resulting C3b activation fragments covalently attach to nearby targets where they direct antigen selection, immune clearance, and cell lysis. Several proteins, including the membrane protein DAF, and the serum protein factor H, limit convertase activity by promoting their irreversible dissociation. An understanding of the biochemical mechanisms providing for their activities would be helpful for the therapeutic control of the complement response.
- Published
- 1999
- Full Text
- View/download PDF
43. Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding.
- Author
-
Hourcade DE, Mitchell LM, and Oglesby TJ
- Subjects
- Amino Acid Sequence, Animals, Binding Sites, COS Cells, Complement Factor B chemistry, Humans, Magnesium metabolism, Molecular Sequence Data, Structure-Activity Relationship, Complement C3b metabolism, Complement Factor B metabolism
- Abstract
Factor B is a zymogen that carries the catalytic site of the complement alternative pathway convertases. During C3 convertase assembly, factor B associates with C3b and is cleaved at a single site by factor D. The Ba fragment is released, leaving the active complex, C3bBb. During the course of this process, the protease domain becomes activated. The type A domain of factor B, also part of Bb, is similar in structure to the type A domain of the complement receptor and integrin, CR3. Previously, mutations in the factor B type A domain were described that impair C3b-binding. This report describes "gain of function" mutations obtained by substituting factor B type A domain amino acids with homologous ones derived from the type A domain of CR3. Replacement of the betaA-alpha1 Mg2+ binding loop residue D254 with smaller amino acids, especially glycine, increased hemolytic activity and C3bBb stability. The removal of the oligosaccharide at position 260, near the Mg2+ binding cleft, when combined with the D254G substitution, resulted in increased affinity for C3b and iC3b, a C3b derivative. These findings offer strong evidence for the direct involvement of the type A domain in C3b binding, and are suggestive that steric effects of the D254 sidechain and the N260-linked oligosaccharide may contribute to the regulation of ligand binding.
- Published
- 1999
44. Measles virus spread and pathogenesis in genetically modified mice.
- Author
-
Mrkic B, Pavlovic J, Rülicke T, Volpe P, Buchholz CJ, Hourcade D, Atkinson JP, Aguzzi A, and Cattaneo R
- Subjects
- Animals, Antigens, CD genetics, Brain pathology, Brain virology, Gene Deletion, Humans, Injections, Interferon-alpha genetics, Interferon-alpha physiology, Interferon-beta genetics, Interferon-beta physiology, Lung pathology, Lung virology, Measles virus physiology, Membrane Cofactor Protein, Membrane Glycoproteins genetics, Mice, Mice, Transgenic, Virus Replication, Antigens, CD metabolism, Measles virus pathogenicity, Membrane Glycoproteins metabolism
- Abstract
Attenuated Edmonston measles virus (MV-Edm) is not pathogenic in standard mice. We show here that MV-Edm inoculated via the natural respiratory route has a limited propagation in the lungs of mice with a targeted mutation inactivating the alpha/beta interferon receptor. A high dose of MV-Edm administered intracerebrally is lethal for about half of these mice. To study the consequences of the availability of a high-affinity receptor for MV propagation, we generated alpha/beta interferon-defective mice expressing human CD46 with human-like tissue specificity. Intranasal infection of these mice with MV-Edm resulted in enhanced spread to the lungs and more prominent inflammatory response. Virus replication was also detected in peripheral blood mononuclear cells, the spleen, and the liver. Moreover, intracerebral inoculation of adult animals with low MV-Edm doses caused encephalitis with almost inevitably lethal outcome. We conclude that in mice alpha/beta interferon controls MV infection and that a high-affinity receptor facilitates, but is not strictly required for, MV spread and pathogenesis.
- Published
- 1998
- Full Text
- View/download PDF
45. The human factor H-related gene 2 (FHR2): structure and linkage to the coagulation factor XIIIb gene.
- Author
-
Skerka C, Moulds JM, Taillon-Miller P, Hourcade D, and Zipfel PF
- Subjects
- Amino Acid Sequence, Base Sequence, Biological Evolution, Chromosomes, Artificial, Yeast, Chromosomes, Human, Pair 1, DNA Primers genetics, DNA, Complementary genetics, Exons, Genetic Linkage, Humans, Molecular Sequence Data, Multigene Family, Complement Factor H genetics, Factor XIII genetics
- Abstract
The human factor H-related gene 2 (FHR2) encodes a serum protein structurally and immunologically related to complement factor H. We describe the isolation and genomic organization of the human FHR2 gene from a yeast artificial chromosome library. The FHR2 gene is organized in five exons and spans about 7 kilobases (kb) of human genomic DNA. A comparison with the corresponding cDNA sequence (clone DDESK59) shows that the analyzed FHR2 gene has a deleted region within exon 4. A new splice acceptor site created in the truncated exon indicates that the analyzed gene could be translated to a truncated protein. Further, we demonstrate that the genes for FHR2 and beta subunit of coagulation factor XIII are located in the same 165 kb YAC DNA. Thus, the three structurally related genes FXIIIb, FHR2, and factor H are linked on human chromosome 1 in the regulators of complement activation (RCA) gene cluster. The physical linkage of the FHR2 and the factor H genes provides additional evidence for a close relatedness of complement factor H and the factor H-related proteins. The linkage and the almost exclusive organization in short consensus repeat-containing domains indicates a close evolutionary relationship of the FXIIIb, FHR2, and factor H genes.
- Published
- 1995
- Full Text
- View/download PDF
46. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
- Author
-
White DJ, Oglesby T, Liszewski MK, Tedja I, Hourcade D, Wang MW, Wright L, Wallwork J, and Atkinson JP
- Subjects
- Animals, B-Lymphocytes immunology, Base Sequence, Blood Proteins immunology, CD55 Antigens, Cell Line, Chromosomes, Human, Pair 1, Cytotoxicity, Immunologic, Humans, Hybrid Cells immunology, Membrane Cofactor Protein, Mice, Molecular Sequence Data, Oligodeoxyribonucleotides, Plasmacytoma immunology, Polymerase Chain Reaction, Rabbits, Transfection, Antigens, CD, Complement System Proteins immunology, Membrane Glycoproteins genetics, Membrane Proteins genetics
- Published
- 1992
47. Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs).
- Author
-
Hourcade D, Garcia AD, Post TW, Taillon-Miller P, Holers VM, Wagner LM, Bora NS, and Atkinson JP
- Subjects
- Amino Acid Sequence, Base Sequence, DNA Probes, Genetic Techniques, Humans, Molecular Sequence Data, Restriction Mapping, Saccharomyces cerevisiae genetics, Complement Activation genetics, Genes, Regulator, Multigene Family
- Abstract
The human regulators of complement activation gene cluster (RCA cluster) have been partially characterized with yeast artificial chromosomes (YACs). While the data confirm many points previously elucidated, the finer resolution of YAC mapping has allowed the discovery and/or localization of partial gene duplications, the determination of gene orientations, and the measurement of gaps between known genes. Here nine overlapping YACs that encompass a genomic region of 800 kb, encoding four RCA genes and three gene-like elements, are described. The encoded genes and two of the gene-like elements share the same orientation and are ordered (5' to 3') DAF, CR2, CR1, MCP-like, CR1-like, and MCP. A C4bp-like region lies upstream from DAF and is likely to correspond to one recently observed by F. Pardo-Manuel, J. Rey-Campos, A. Hillarp, B. Dahlback, and S. Rodriguez de Cordoba (1990, Proc. Natl. Acad. Sci. USA 87: 4529-4533). MCP-like, a new genetic element, was discovered and found to be homologous to the 5' portion of the MCP gene. Two large gaps of 85 kb (between CR2 and DAF) and 110 kb (between DAF and the C4bp-like element) could carry additional RCA genes. The arrangement of CR1, MCP-like, CR1-like, and MCP, in that order, strongly suggests that this region was generated by a single duplication of neighboring CR1/CR1-like and MCP/MCP-like forerunners. The RCA YACs will now serve as convenient DNA sources for the subcloning and further characterization of this region.
- Published
- 1992
- Full Text
- View/download PDF
48. Polymorphisms of the regulators of complement activation gene cluster.
- Author
-
Hourcade D, Post TW, Holers VM, Lublin DM, and Atkinson JP
- Subjects
- Amino Acid Sequence, Biological Evolution, Genetic Linkage, Genetic Variation, Humans, Molecular Sequence Data, Complement Activation genetics, Genes, Regulator, Multigene Family, Polymorphism, Genetic
- Abstract
The regulators of complement activation (RCA) constitute a tightly linked gene family that controls the activity of the complement system. Genetic polymorphisms have been reported for all of RCA genes at the DNA, RNA and/or protein levels. In addition, multiple RNA and/or protein products have been observed for most of these genes. These polymorphisms and variants are instrumental in the study of the structure, evolution and function of the RCA family.
- Published
- 1990
- Full Text
- View/download PDF
49. Marker rescue from bleomycin-treated Chlamydomonas reinhardi.
- Author
-
Hourcade DE
- Subjects
- Chlamydomonas genetics, Genes drug effects, Bleomycin pharmacology, Chromosomes drug effects, Genetic Markers drug effects, Genetic Techniques, Recombination, Genetic
- Abstract
A new method has been developed for gene transfer in eukaryotic cells. Chlamydomonas reinhardi, a unicellular eukaryotic alga, was treated with a lethal dose of bleomycin, an agent that induces chromosome breakage. Bleomycin-treated cells were mated with untreated cells, and the mixture was plated onto selective agar medium. The progeny that arose contained the genetic markers from the untreated parent plus a subset of the genetic markers from the bleomycin-treated parent. Those markers derived from the untreated parent were stable, whereas those recovered from the bleomycin-treated parent were often unstable. Markers closely linked in the bleomycin-treated parent were usually rescued or lost together, whereas distantly linked or unlinked markers were rescued or lost independently. These results suggest that bleomycin treatment of C. reinhardi leads to the formation of chromosome fragments, and fusion of bleomycin-treated cells to untreated cells results in the rescue of some of these fragments. This procedure provides a new means of gene transfer that may be useful for genetic mapping, genetic engineering and for the study of genetic organization.
- Published
- 1983
- Full Text
- View/download PDF
50. The regulators of complement activation (RCA) gene cluster.
- Author
-
Hourcade D, Holers VM, and Atkinson JP
- Subjects
- Amino Acid Sequence, Complement System Proteins genetics, Genes, Regulator, Humans, Molecular Sequence Data, Repetitive Sequences, Nucleic Acid, Complement Activation, Multigene Family
- Published
- 1989
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.